Palvella Therapeutics

PVLA • XNAS

Palvella Therapeutics is a pharmaceutical preparations company trading on XNAS, led by CEO Wesley H. Kaupinen, with a market cap of $1.6B.

CEOWesley H. Kaupinen

Market Cap$1.6B

PHARMACEUTICAL PREPARATIONS

Next Earnings

Upcoming earnings announcement for Palvella Therapeutics

Date

Thursday, May 14, 2026 (in a month)

Timing

Before Market Open (7:00 AM New York)

Fiscal Period

Q1 2026

EPS Estimate

-$0.86

Past 4 earnings reports for Palvella Therapeutics

Date	Period	EPS	EPS Surprise	Revenue	Rev. Surprise	Filing
Nov 11, 2025	Q3 2025	-$1.03Est: -$0.85	-21.2%	-	—	10-Q
Aug 14, 2025	Q2 2025	-$0.86Est: -$0.77	-11.7%	-	—	10-Q
May 15, 2025	Q1 2025	-$0.74Est: -$1.32	+43.9%	-	—	10-Q
Mar 31, 2025	Q4 2024	-$5.37Est: -$3.02	-77.8%	-	—	10-K